Ascendis Pharma A/S
AGA
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
323 / 1361
Position in country
121 / 253
Return on Assets, %
-53.8
-40.3
Net income margin, %
-63.1
-180
EBITDA margin, %
-23
-168.2
Intangible assets and goodwill, %
0.5
0.2
Revenue CAGR 3Y, %
237.2
12.5
Total Equity change 1Y, %
-157.1
-9
Revenue Y, % chg
443.6
0
P/BV
-54.4
1.8
P/S
29.6
10.3
EV/S
30.6
7.5
EV/EBITDA
-16.3
-1.6
Average Analyst recommendation
Buy
Buy
Average upside forecasts, %
17.6
131.1
Expected dividend per share
0
0
Competitors
Ranks
-
Bavarian Nordic A/S
00%
-
Vertex Pharmaceuticals Inc
00%
-
CSL Ltd
00%
-
Regeneron Pharmaceuticals Inc
00%
-
Gilead Sciences Inc
00%
-
Genmab A/S
00%
-
Ascendis Pharma A/S
00%
-
Zealand Pharma A/S
00%
-
Amgen Inc
00%
-
AbbVie Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
Denmark
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Sub-sector
Health Care
Capitalization (millions of $)
8427.5
Ticker
ASND.O
ISIN
US04351P1012
IPO date
2015-01-28
Availability on Russian exchanges
No
Reporting for
2024-02-07
Date fact. publication of reports
2023-12-31
Company Description
ASCENDIS PHARMA A/S is a Danish-based biopharmaceutical company, which is involved in manufacture products for rare diseases. The Company utilizes its TransCon technologies for treatment, which can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs. The Company is headquartered in Copenhagen, Denmark with offices in Heidelberg, Germany and Palo Alto, California.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: